Abstract:BACKGROUND:The constitutively existed tumor stem cells in the microenvironment of bone marrow changed the characteristics of marrow stromal cells and extracellular matrix,and involved in the malignancy of hematopoietic stem cells.OBJECTIVE:To investigate the matrix metalloproteinase-9(MMP-9) expression in bone marrow mesenchymal stem cells(BMSCs) in chronic myelocytic leukemia patients and its adhesive effects on hematopoietic stem cells.DESIGN,TIME AND SETTING:The cytology in vitro controlled study was performed at the Basic College,Peking Union Medical College from September 2007 and February 2008.MATERIALS:Bone marrow samples,which were collected from 4 chronic myelocytic leukemia patients and 4 healthy volunteers,were obtained from the Department of Hematology,the 309 Hospital of Chinese PLA.Umbilical cord blood was provided by Beijing Umbilical Cord Blood Hematopoietic Stem Cell Pool.293T cells were presented by Professor Kong from Nankai University.METHODS:Bone marrow was harvested from healthy volunteers and chronic myelocytic leukemia patients.BMSCs were collected by the Ficoll method in vitro.Umbilical cord blood was separately packed,centrifuged to remove the supernatant.The intermedium was taken.Umbilical cord blood mononuclear cells were isolated and obtained by the same method.BMSCs in the logarithmic phase were incubated in a 96-well culture plate at 1×107/L per well.When 100% cells were confluent,umbilical cord blood mononuclear cells were incubated in the same culture plate at 1×105 per well for 1 hour.Following non-adherent cells were removed,adherent rate was calculated.At the second passage,BMSCs were harvested.Mass concentration of soluble intercellular adhesion molecule-1 in the supernatant was measured by enzyme linked immunosorbent assay.MPP-9 siRNA interference vector was constructed.293T cells were transfected and encased by the liposome method.BMSCs were transfected following virus amplification.MAIN OUTCOME MEASURES:Five indexes were compared between healthy donors and chronic myelocytic leukemia patients.Three indexes were compared among chronic myelocytic leukemia patients before and after virus transfection.RESULTS:Compared with the healthy donors,MMP-9 mRNA and protein levels in BMSCs were significantly increased in the chronic myelocytic leukemia patients,and no significant differences were detected in intercellular adhesion molecule-1,and mass concentration of soluble intercellular adhesion molecule-1 was significantly increased in the supernatant(P < 0.05).Adherent rate of umbilical cord blood mononuclear cells were significant decreased(P < 0.05).Compared with the non-transfection BMSCs,MMP-9 mRNA expression was significant reduced following virus transfection,and intercellular adhesion molecule-1 protein expression was not affected,and the adherent rate of umbilical cord blood mononuclear cells was significantly increased(P < 0.05).CONCLUSION:The action mechanism of MMP-9-splited intercellular adhesion molecule-1 exists in BMSCs from chronic myelocytic leukemia patients.It is hypothesized that free soluble intercellular adhesion molecule-1 blocks the binding site of LFA-1,and finally affects the adherence of BMSCs on hematopoietic stem cells.

Bone Morphogenetic Protein 9 Regulates the Cross-Talk Between Breast Cancer Cells and Bone Marrow Mesenchymal Stem Cells

BMP9 Regulates Cross-Talk Between Breast Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells.

Biological Roles of Human Bone Morphogenetic Protein 9 in the Bone Microenvironment of Human Breast Cancer MDA-MB-231 Cells.

Effects of human bone morphogenetic protein 9 on migration and apoptosis of human breast cancer cells in simulated bone microenvironment in vitro

Effects of BMP9 over-expression on proliferation and migration of human breast cancer MDA-MB-231 cells in simulated breast adipose microenvironment in vitro and its possible mechanism

BMP9 Inhibits Proliferation and Metastasis of HER2-positive SK-BR-3 Breast Cancer Cells Through ERK1/2 and PI3K/AKT Pathways.

Bone Morphogenetic Protein 9 Overexpression Reduces Osteosarcoma Cell Migration and Invasion

Bone morphogenetic protein 9 enhances osteogenic and angiogenic responses of human amniotic mesenchymal stem cells cocultured with umbilical vein endothelial cells through the PI3K/AKT/m-TOR signaling pathway

Role of cAMP-PKA-CREB signal pathway in regulation of osteogenic differentiation of murine mesenchymal stem cells by bone morphogenetic protein 9

Bmp-9-Induced Osteogenic Differentiation of Mesenchymal Progenitors Requires Functional Canonical Wnt/Beta-Catenin Signalling

BMP9 induces osteogenic differentiation through up-regulating LGR4 via the mTORC1/Stat3 pathway in mesenchymal stem cells

Sonic Hedgehog potentiates BMP9-induced osteogenic differentiation of mesenchymal stem cells

MicroRNA-155 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells Induced by BMP9 Via Downregulation of BMP Signaling Pathway.

Overexpression of Mir-155 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells C3H10T1/2 Induced by BMP9

Matrix metalloproteinase-9 expression in bone marrow mesenchemyl stem cells of chronic myeloid leukemia patients and its effects on hematopoietic stem cell adherence

hBMP-7 Gene Modified Bone Marrow Stromal Cells on the Effects of Healing of Periodontal Furcation Defects in Osteoporosis Rats

Bone Morphogenetic Protein 10 (Bmp-10) Inhibits Growth of Breast Cancer Cells and Correlates with Poor Prognosis

BMP-9 Improves the Osteogenic Differentiation Ability over BMP-2 through p53 Signaling In Vitro in Human Periosteum-Derived Cells

Effects of Human Bone Morphogenetic Protein- 7 Gene on Bone Marrow Stromal Cell in Vitro

The BMP signaling pathway enhances the osteoblastic differentiation of bone marrow mesenchymal stem cells in rats with osteoporosis

TGFβ/BMP Type I Receptors ALK1 and ALK2 Are Essential for BMP9-induced Osteogenic Signaling in Mesenchymal Stem Cells